Hjem › Kreft (alle typer) › Minnesota › Rochester
Kliniske studier for Kreft (alle typer) i Rochester, MN
30 studier for Kreft (alle typer) søker deltakere på steder i og rundt Rochester (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RekruttererFase 3
- Investigative Site, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- Mayo Clinic Rochester, Rochester
A Study of JNJ-1761981 in Participants With Solid Tumors
RekruttererFase 1
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruttererFase 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruttererFase 3
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- Mayo Clinic, Rochester
Statins to Prevent Cancer Associated Blood Clots
RekruttererFase 4
- Mayo Clinic, Rochester
Biomarkers of Resiliency In Childhood Cancer Surgery
RekruttererObservasjonsstudie
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RekruttererFase 1/2
- Mayo Clinic Rochester, Rochester
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RekruttererObservasjonsstudie
- Mayo Clinic Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Mayo Clinic in Rochester, Rochester
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekruttererFase 3
- Mayo Clinic, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Mayo Clinic, Rochester
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Mayo Clinic in Rochester, Rochester
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Mayo Clinic - Rochester /ID# 251164, Rochester
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekruttererFase 2
- Mayo Clinic-Rochester /ID# 273508, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruttererFase 1
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Mayo Clinic Rochester, Rochester
Patient Derived Preclinical Models
RekruttererObservasjonsstudie
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Rekrutterer
- Mayo Clinic, Rochester
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
RekruttererFase 1
- Mayo Clinic Rochester, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Mayo Clinic, Rochester
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
RekruttererObservasjonsstudie
- Mayo Clinic in Rochester, Rochester
Multi-Cancer Detection Observational Cohort Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mayo Clinic in Rochester, Rochester
Suprachoroidal Administration in Subjects With Metastases to the Choroid
RekruttererFase 2
- Mayo Clinic, Rochester
Primary Tumor Research and Outcomes Network
RekruttererObservasjonsstudie
- Mayo Clinic, Rochester
Testicular Tissue Cryopreservation in Children
Rekrutterer
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Mayo Clinic, Rochester
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY110 studier
- Boston, MA86 studier
- Los Angeles, CA73 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Durham, NC58 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Seattle, WA49 studier
- Atlanta, GA49 studier
- Arlington, VA48 studier
Andre studier i Rochester
- Brystkreft42 studier
- Ikke-småcellet lungekreft37 studier
- Metastatisk kreft31 studier
- Kolorektal kreft29 studier
- Eggstokkreft29 studier
- Multipelt myelom24 studier
- Prostatakreft22 studier
- Hjertesvikt22 studier
- Pankreaskreft22 studier
- Lungekreft20 studier
- Endometriekreft20 studier
- Kronisk lymfatisk leukemi19 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.